Genomic Features of Response to Combination Immunotherapy in Lung Cancer

被引：17
作者：
Frueh, Martin [1 ]
Peters, Solange [2 ]
机构：
[1] Cantonal Hosp St Gallen, Dept Med Oncol Hematol, St Gallen, Switzerland
[2] Univ Hosp Lausanne CHUV, Dept Med Oncol, CH-1011 Lausanne, Switzerland
来源：
CANCER CELL | 2018年 / 33卷 / 05期
关键词：
NIVOLUMAB PLUS IPILIMUMAB; MUTATIONAL LANDSCAPE; CTLA-4; BLOCKADE; OPEN-LABEL; MELANOMA;
D O I：
10.1016/j.ccell.2018.04.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this issue of Cancer Cell, Hellmann et al. describe in two clinical trials the importance of tumor mutational burden as an independent predictive marker for outcomes with combination nivolumab plus ipilimumab as first-line therapy in metastatic non-small-cell lung cancer and in relapsed small-cell lung cancer.
引用
收藏
页码：791 / 793
页数：3
相关论文
共 50 条
  • [21] Landscape of Combination Immunotherapy and Targeted Therapy to Improve Cancer Management
    Colli, Leandro M.
    Machiela, Mitchell J.
    Zhang, Han
    Myers, Timothy A.
    Jessop, Lea
    Delattre, Olivier
    Yu, Kai
    Chanock, Stephen J.
    CANCER RESEARCH, 2017, 77 (13) : 3666 - 3671
  • [22] Mechanisms of immunotherapy resistance in small cell lung cancer
    Nie, Yunan
    Schalper, Kurt A.
    Chiang, Anne
    CANCER DRUG RESISTANCE, 2024, 7
  • [23] Response to Immunotherapy in Combination With Mitotane in Patients With Metastatic Adrenocortical Cancer
    Head, Lia
    Kiseljak-Vassiliades, Katja
    Clark, Toshimasa J.
    Somerset, Hilary
    King, Jonathan
    Raeburn, Christopher
    Albuja-Cruz, Maria
    Weyant, Michael
    Cleveland, Joseph
    Wierman, Margaret E.
    Leong, Stephen
    JOURNAL OF THE ENDOCRINE SOCIETY, 2019, 3 (12) : 2295 - 2304
  • [24] The Immunotherapy for Colorectal Cancer, Lung Cancer and Pancreatic Cancer
    Chen, Shiu-Jau
    Wang, Shao-Cheng
    Chen, Yuan-Chuan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)
  • [25] Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors
    Kovacs, Szonja Anna
    Fekete, Janos Tibor
    Gyorffy, Balazs
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (9) : 1879 - 1889
  • [26] Integration of tumor extrinsic and intrinsic features associates with immunotherapy response in non-small cell lung cancer
    Lau, Denise
    Khare, Sonal
    Stein, Michelle M.
    Jain, Prerna
    Gao, Yinjie
    BenTaieb, Aicha
    Rand, Tim A.
    Salahudeen, Ameen A.
    Khan, Aly A.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [27] Immunotherapy in Small Cell Lung Cancer
    Esposito, Giovanna
    Palumbo, Giuliano
    Carillio, Guido
    Manzo, Anna
    Montanino, Agnese
    Sforza, Vincenzo
    Costanzo, Raffaele
    Sandomenico, Claudia
    La Manna, Carmine
    Martucci, Nicola
    La Rocca, Antonello
    De Luca, Giuseppe
    Piccirillo, Maria Carmela
    De Cecio, Rossella
    Botti, Gerardo
    Totaro, Giuseppe
    Muto, Paolo
    Picone, Carmine
    Normanno, Nicola
    Morabito, Alessandro
    CANCERS, 2020, 12 (09) : 1 - 17
  • [28] Immunotherapy in Lung Cancer and the Role of Imaging
    Carter, Brett W.
    SEMINARS IN ULTRASOUND CT AND MRI, 2018, 39 (03) : 314 - 321
  • [29] Advances in the Lung Cancer Immunotherapy Approaches
    Padinharayil, Hafiza
    Alappat, Reema Rose
    Joy, Liji Maria
    Anilkumar, Kavya V.
    Wilson, Cornelia M.
    George, Alex
    Valsala Gopalakrishnan, Abilash
    Madhyastha, Harishkumar
    Ramesh, Thiyagarajan
    Sathiyamoorthi, Ezhaveni
    Lee, Jintae
    Ganesan, Raja
    VACCINES, 2022, 10 (11)
  • [30] The Resistance Mechanisms of Lung Cancer Immunotherapy
    Wang, Fen
    Wang, Shubin
    Zhou, Qing
    FRONTIERS IN ONCOLOGY, 2020, 10
12345